You pick up a supplement bottle in a New Zealand pharmacy. The label says "liposomal." You assume someone - Medsafe, the government, somebody - has verified that claim before it reached the shelf. It is a reasonable assumption. It is also completely wrong.

New Zealand's supplement regulations date from 1985. They predate liposomal technology, the internet, and the modern supplement industry. Unlike food or pharmaceuticals, dietary supplements require no pre-market approval whatsoever ^[1]. Every quality claim on that bottle is self-declared by the company selling it to you.

What does "regulated" actually mean for supplements here?

Most New Zealanders assume supplements undergo some form of government testing before sale. The reality is blunter than you might expect.

Medsafe states explicitly: "There is no pre-approval process for dietary supplements" ^[1]. Sponsors self-certify that their products meet the 1985 regulations. No one checks. The Dietary Supplements Regulations 1985 set maximum daily doses for some vitamins and minerals, but contain zero provisions for delivery technology claims, encapsulation efficiency, or liposomal verification ^[2].

That means the word "liposomal" on a New Zealand supplement label carries no regulatory weight at all. It is a marketing descriptor, not a verified manufacturing specification. The Commerce Commission requires claims to be accurate, but enforcement is complaint-driven - someone has to report a problem before anyone investigates ^[3].

Compare that to what happened in the UK. The Advertising Standards Authority ruled that YourZooki, one of the most prominent liposomal vitamin C brands globally, had not provided conclusive evidence its product actually contained liposomes ^[9][10]. That level of scrutiny simply does not exist in New Zealand's current framework.

How exposed are you right now?

The gap between what consumers believe and what the regulations deliver is significant:

• No pre-market approval. Supplements reach shelves without any government body verifying ingredient quality, dose accuracy, or delivery-method claims ^[1].
• No liposome-specific standards. The 1985 regulations were written decades before liposomal delivery existed. They contain no framework for evaluating whether a "liposomal" product contains actual liposomes ^[2].
• Complaint-driven enforcement. The Commerce Commission acts on inaccurate claims, but only after someone complains ^[3]. Proactive market surveillance does not happen.
• Label claims are unreliable across the industry. A March 2025 analytical report found that only 24% of top-selling NAD+ supplements met their labelled claims ^[8]. That failure rate is industry-wide, not limited to fringe brands.
• "Clinically proven" drives purchases. Research shows this is the single most powerful phrase for consumer purchase intent ^[12] - yet no New Zealand authority verifies whether the clinical evidence behind that phrase applies to the specific product on shelf.

What this actually costs you

Picture yourself spending $50 a month on a liposomal vitamin C supplement. You chose it specifically because the label promised superior absorption. You take it daily through winter, confident you are getting measurable immune support.

Twelve months later you have spent $600. But no one verified the product contains functional liposomes. No regulatory body checked encapsulation efficiency. The "clinically proven" claim may reference a study on an entirely different formulation. You made a health decision based on claims no one in New Zealand is required to substantiate before sale.

That is not just a financial cost. It is a trust cost - compounding every month you continue buying on unverified label language.

How should you protect yourself?

Until regulation catches up, the responsibility sits with you. Use these filters before purchasing any supplement making delivery-technology claims:

• Demand third-party verification. Does the brand publish independent lab data - cryo-TEM imaging or dynamic light scattering - confirming liposomal structures actually exist in the finished product?
• Check encapsulation efficiency. Genuine liposomal products should report rates above 70%. If a brand cannot state this figure, they likely have not measured it.
• Scrutinise "clinically proven" claims. Was the study conducted on the exact product and formulation being sold, or on a different product using similar ingredients?
• Look for phospholipid-to-nutrient ratios. Functional liposomes require ratios between 1:5 and 1:20. Products outside this range cannot form effective vesicles.

What happens next - and what to do now

New Zealand's regulatory landscape is shifting. Cabinet decided in 2025 to regulate natural health products under separate standalone legislation, and the Medical Products Bill is expected in Parliament in 2026 ^[4][5]. Full implementation is estimated around 2030. The previous attempt - the Therapeutic Products Act - was repealed before ever taking effect ^[6].

That timeline means at least four more years of the current vacuum. Here is how to navigate it.

Treat every label claim as unverified until proven otherwise. In a self-certification system, the burden of proof belongs to you, not the regulator.

Contact the brand directly. Ask for published structural verification of their liposomal claims. Companies with genuine liposomal technology are proud to share the data. Silence or deflection is your answer.

Compare regulatory standards across markets. Products that have passed scrutiny in stricter jurisdictions - the UK, EU, or Australia's TGA framework - carry more credibility than those sold only where oversight is minimal.

Do not wait for regulation to protect you. The brands doing liposomal delivery properly already exceed what New Zealand law requires. Find them, verify them, and buy from them. The regulatory gap is real, but it does not have to be your gap.